Literature DB >> 27468899

The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.

C Gao1, J Qiao1, S S Li1, W J Yu1, J W He1, W Z Fu1, Z L Zhang2.   

Abstract

This study evaluated the levels of bone turnover markers (BTMs) and investigated relationships between them and bone mineral density (BMD) in postmenopausal women in China suburban district. The prevalence of osteoporosis was 25.03 % at lumbar spine and 6.23 % at femoral neck, and BTMs were negatively correlated with BMDs.
INTRODUCTION: The aims of this study were to evaluate the levels of bone turnover markers (BTMs), including serum N-terminal procollagen of type I collagen (P1NP), beta C-terminal cross-linked of type I collagen (β-CTX), 25-hydroxyvitamin D [25(OH)D], and parathyroid hormone (PTH), and to investigate relationships between these markers and bone mineral density (BMD) as well the prevalence of osteoporosis in postmenopausal women of suburban district.
METHODS: A population of 4822 postmenopausal women aged 55-69 years old (62.22 ± 6.75) from the suburban district was recruited voluntarily. BMD was measured at the lumbar spine, femoral neck, and total hip using dual-energy X-ray absorptiometry; 2251 women in this group had the serum BTMs 25(OH)D and PTH tested.
RESULTS: The prevalence of osteoporosis was 25.03 % at lumbar spine and 6.23 % at femoral neck. The median (interquartile range) values of serum P1NP, β-CTX, 25(OH)D, and PTH were 59.3 ng/mL (44.7-75.52), 0.370 ng/mL (0.280-0.490), 23.0 ng/mL (17.1-30.5), and 31.4 pg/mL (24.9-39.7), respectively. Serum P1NP and β-CTX levels presented significantly negative correlations with BMDs at the all the sites (Betastd = -0.098 to -0.208, respectively, P < 0.001), whereas PTH levels were negatively correlated with BMDs of the femoral neck and total hip (Betastd = -0.062 and -0.054, P < 0.01, respectively). Serum 25(OH)D had positive associations with BMDs at total hip (Betastd = 0.051, P < 0.01).
CONCLUSIONS: The BMD of postmenopausal women in China suburban area is higher than that in downtown area, and over 60 % of the participants had their serum 25(OH)D level over 20 ng/mL. BTMs were negatively correlated with BMDs, suggesting that BTMs are reliable factors for early declines in BMD.

Entities:  

Keywords:  25(OH)D; Bone mineral density; Bone turnover markers; PTH; Shanghai suburban district

Mesh:

Substances:

Year:  2016        PMID: 27468899     DOI: 10.1007/s00198-016-3692-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  29 in total

1.  Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.

Authors:  P Garnero; F Munoz; E Sornay-Rendu; P D Delmas
Journal:  Bone       Date:  2006-11-16       Impact factor: 4.398

2.  Effects of the sample size of reference population on determining BMD reference curve and peak BMD and diagnosing osteoporosis.

Authors:  Y-L Hou; E-Y Liao; X-P Wu; Y-Q Peng; H Zhang; R-C Dai; X-H Luo; X-Z Cao
Journal:  Osteoporos Int       Date:  2007-08-03       Impact factor: 4.507

3.  Vitamin D, parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study.

Authors:  Denise G von Mühlen; Gail A Greendale; Cedric F Garland; Lori Wan; Elizabeth Barrett-Connor
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

4.  PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly.

Authors:  A Arabi; R Baddoura; R El-Rassi; G El-Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2011-06-08       Impact factor: 4.507

5.  Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women.

Authors:  P Mezquita-Raya; M Muñoz-Torres; J D Luna; V Luna; F Lopez-Rodriguez; E Torres-Vela; F Escobar-Jiménez
Journal:  J Bone Miner Res       Date:  2001-08       Impact factor: 6.741

6.  Age and sex effects on the association between body composition and bone mineral density in healthy Chinese men and women.

Authors:  Qun Cheng; Ying Xiao Zhu; Mei Xue Zhang; Lin Hui Li; Ping Yan Du; Min Han Zhu
Journal:  Menopause       Date:  2012-04       Impact factor: 2.953

7.  Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective.

Authors:  Natalia O Kuchuk; Natasja M van Schoor; Saskia M Pluijm; Arkadi Chines; Paul Lips
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

8.  Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial.

Authors:  M E Ooms; J C Roos; P D Bezemer; W J van der Vijgh; L M Bouter; P Lips
Journal:  J Clin Endocrinol Metab       Date:  1995-04       Impact factor: 5.958

9.  [Nutritional factors in preventing osteoporosis].

Authors:  Juan Antonio Martín Jiménez; Belkis Consuegra Moya; María Teresa Martín Jiménez
Journal:  Nutr Hosp       Date:  2015-07-18       Impact factor: 1.057

10.  High prevalence of vitamin D insufficiency in China: relationship with the levels of parathyroid hormone and markers of bone turnover.

Authors:  Han-Kui Lu; Zeng Zhang; Yao-Hua Ke; Jin-Wei He; Wen-Zhen Fu; Chang-Qing Zhang; Zhen-Lin Zhang
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

View more
  8 in total

1.  Effect of serum 25-hydroxyvitamin D concentrations on skeletal mineralization in black and white women.

Authors:  Shijing Qiu; Sudhaker D Rao
Journal:  J Bone Miner Metab       Date:  2021-06-14       Impact factor: 2.626

2.  The Imbalance of Cytokines and Lower Levels of Tregs in Elderly Male Primary Osteoporosis.

Authors:  Wei Zhang; Wei Zhao; Wei Li; Qi Geng; Rui Zhao; Yungui Yang; Luyan Lv; Weiwen Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-31       Impact factor: 6.055

3.  Association of serum 25-hydroxyvitamin D (25(OH)D) levels with the gut microbiota and metabolites in postmenopausal women in China.

Authors:  Jinhua Gong; Lina He; Qinyuan Zou; Yangyang Zhao; Bangzhou Zhang; Rongmu Xia; Baolong Chen; Man Cao; Wenxiu Gong; Lin Lin; Xiujuan Lin; Guowei Wang; Muyun Guo; Jianquan He; Chuanxing Xiao; Jian Chen
Journal:  Microb Cell Fact       Date:  2022-07-11       Impact factor: 6.352

4.  Association between serum levels of bone turnover markers and bone mineral density in men and women with type 2 diabetes mellitus.

Authors:  Chenhe Zhao; Guangwang Liu; Yao Zhang; Guiping Xu; Xilu Yi; Jing Liang; Yinqiu Yang; Jun Liang; Chao Ma; Yangli Ye; Mingxiang Yu; Xinhua Qu
Journal:  J Clin Lab Anal       Date:  2019-11-15       Impact factor: 2.352

5.  Association between bone turnover markers, BMD and height loss of cemented vertebrae after percutaneous vertebroplasty in patients with osteoporotic vertebral compression fractures.

Authors:  Shangjin Lin; Xiaoxi Cai; Qun Cheng; Cong Chen; Xuhai Cao; Fengjian Yang; Yongqian Fan
Journal:  J Orthop Surg Res       Date:  2022-04-04       Impact factor: 2.359

6.  Lower Serum Fibroblast Growth Factor 21 Levels are Associated with Normal Lumbar Spine Bone Mineral Density in Hemodialysis Patients.

Authors:  Yin-Ting Wu; Bang-Gee Hsu; Chih-Hsien Wang; Yu-Li Lin; Yu-Hsien Lai; Chiu-Huang Kuo
Journal:  Int J Environ Res Public Health       Date:  2020-03-16       Impact factor: 3.390

7.  Ethnic, geographic, and seasonal differences of vitamin D status among adults in south-west China.

Authors:  Lin Li; Kecheng Li; Jing Li; Yulei Luo; Yuheng Cheng; Meiling Jian; Chunbao Xie; Chengjie Ji; Liangmin Chuan; Zhibin Wang; Haijun Li; Xiaolan Guo; Jinbo Liu; Li Jiang
Journal:  J Clin Lab Anal       Date:  2020-08-26       Impact factor: 3.124

8.  Lower bone mineral density and higher bone resorption marker levels in premenopausal women with type 1 diabetes in Japan.

Authors:  Fumi Yoshioka; Shinsuke Nirengi; Takashi Murata; Yaeko Kawaguchi; Tomokazu Watanabe; Kunio Saeki; Muneto Yoshioka; Naoki Sakane
Journal:  J Diabetes Investig       Date:  2021-04-03       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.